RE:Looks good to me
That this technology is life changing and they are showing very promising results. The Aspire lawsuit was simply a roadblock from getting this therapy to market. I don't know if you guys realize that Kyle Makofka (Apsire CEO) was also Hemostemix's CEO at one point. So he had the insider scoop and obviously knows the potential results/revenue this can bring...